Quick Takeaways
- ORBIS INVESTMENT MANAGEMENT LTD filed SCHEDULE 13G for Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share (PRAX).
- Disclosed ownership: 5%.
- Date of event: 31 Dec 2025.
ORBIS INVESTMENT MANAGEMENT LTD - 31 Dec 2025 SCHEDULE 13G Report for Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share (PRAX)
- Filing Manager
- ORBIS INVESTMENT MANAGEMENT LTD
- Reporting Manager
- ORBIS INVESTMENT MANAGEMENT LTD
- Symbol
- PRAX
- Shares outstanding
- 25,051,460 shares
- Disclosed Ownership
- 1,252,573 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 12:10:27 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIS INVESTMENT MANAGEMENT LTD disclosed 5% ownership in Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share (PRAX) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 12:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIS INVESTMENT MANAGEMENT LTD | 5% | 1,252,573 | 1,252,573 | 0 | Matthew Gaarder | Attorney-in-Fact | |
| Allan Gray Australia Pty Ltd | 0% | 2,589 | 2,589 | 0 | Matthew Gaarder | Attorney-in-Fact |